Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Meredith

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Cardiology|September 28, 2001
Is postural hypotension a real problem with antihypertensive medication?P A Meredith
Blood Pressure. Supplement|October 31, 2001
Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockersP A Meredith
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Clinical relevance of optimal pharmacokinetics in the treatment of hypertensionP A Meredith
Journal. Association of American Medical Colleges|February 19, 2014
The student clinicopathologic conference, a device for the teaching of advanced pathologyM LEV, P A MEREDITH
Drugs & Aging|December 31, 1997
Clinical pharmacokinetics of nifedipine. Implications for the care of the elderlyH L Elliott, P A Meredith
Journal of Cardiovascular Pharmacology|January 1, 1994
FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug AdministrationP A Meredith, H L Elliott
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1990
Concentration-effect relationships and antihypertensive mechanisms: ketanserin in the treatment of essential hypertensionH L Elliott, P A Meredith
Blood Pressure. Supplement|May 3, 2001
Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. IntroductionP A Meredith, M A Weber
Clinical Pharmacology and Therapeutics|June 1, 1992
An additive or synergistic drug interaction: application of concentration-effect modelingP A Meredith, H L Elliott
British Journal of Clinical Practice. Supplement|May 1, 1994
Therapeutic coverage: reducing the risks of partial complianceP A Meredith, H L Elliott
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Cardiology|September 28, 2001
Is postural hypotension a real problem with antihypertensive medication?P A Meredith
Blood Pressure. Supplement|October 31, 2001
Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockersP A Meredith
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Clinical relevance of optimal pharmacokinetics in the treatment of hypertensionP A Meredith
Journal. Association of American Medical Colleges|February 19, 2014
The student clinicopathologic conference, a device for the teaching of advanced pathologyM LEV, P A MEREDITH
Drugs & Aging|December 31, 1997
Clinical pharmacokinetics of nifedipine. Implications for the care of the elderlyH L Elliott, P A Meredith
Journal of Cardiovascular Pharmacology|January 1, 1994
FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug AdministrationP A Meredith, H L Elliott
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1990
Concentration-effect relationships and antihypertensive mechanisms: ketanserin in the treatment of essential hypertensionH L Elliott, P A Meredith
Blood Pressure. Supplement|May 3, 2001
Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. IntroductionP A Meredith, M A Weber
Clinical Pharmacology and Therapeutics|June 1, 1992
An additive or synergistic drug interaction: application of concentration-effect modelingP A Meredith, H L Elliott
British Journal of Clinical Practice. Supplement|May 1, 1994
Therapeutic coverage: reducing the risks of partial complianceP A Meredith, H L Elliott
Pageof 21